Filing Flows › Agape ATP (ATPC) › Q1 2025
Agape ATP (ATPC) Q1 2025 earnings results (first quarter 2025)
10-Q filed May 15, 2025
Agape ATP (ATPC) reported revenue of $289K for the first quarter 2025 (Q1 2025), -9% from a year earlier and -20% from the quarter before. Operating margin was -249.2%, net loss $699K (241.8% of revenue).
Agape ATP, Q1 2025: revenue $289K (-9% year over year), operating margin -249.2%, net loss $699K, operating cash flow −$1.5M. The chart follows the revenue to costs, profit and cash.
| Q1 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $289K | -20% | -9% |
| Operating profit | −$720K | — | — |
| Net earnings | −$699K | — | — |
| Operating cash flow | −$1.5M | — | — |
What changed
Revenue was $289K in Q1 2025, down 9% year over year and down 20% from the previous quarter. Product Health Therapies was the largest line at 72% of revenue. LIVO 5 lost $23K year over year (down 75%), 78% of the total change.
Gross margin was 54.1%, down 9.8 points from a year earlier. Operating costs exceeded revenue by $720K, an operating margin of -249.2%. Operating expenses fell 5% while revenue fell 9%. The fastest-growing cost line was Sales & marketing (+25%). The quarter ended with a net loss of $699K, narrower than the previous quarter's $827K loss.
Operating cash flow was −$1.5M. Non-cash charges added back $14K of depreciation and amortization. Working capital and other items used $769K. Capital expenditures of $1K exceeded it, leaving free cash flow of −$1.5M.
Questions
What was Agape ATP's revenue in the first quarter 2025?
Agape ATP (ATPC) reported revenue of $289K for the first quarter 2025 (Q1 2025), -9% from a year earlier and -20% from the quarter before.
Was Agape ATP profitable in the first quarter 2025?
Operating loss was $720K (-249.2% of revenue) and net loss $699K.
Source: Agape ATP 10-Q on SEC EDGAR.